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Pharyngeal pouchThe parathyroid glands originate from the endoderm of the caudal pharyngeal pouches. How these
parathyroids are restricted to developing in the caudal pouches is unclear. In this paper we investigate the role
of Shh signalling in patterning the vertebrate pharyngeal pouches, and show that Hh signalling may be
involved in restricting the expression of the parathyroid marker Gcm2 in the pharyngeal epithelium. In the
chick and mouse, Shh signalling is excluded or highly reduced in the posterior/caudal pouches, where the
parathyroid marker Gcm2 is expressed, while remaining at high levels in the more anterior pouches.
Moreover, though the block of Shh signalling at early developmental stages results in the loss of chick Gcm2
expression, at later stages, it induces ectopic Gcm2 expression domains in the second and ﬁrst pharyngeal
epithelium, suggesting that HH signalling prevents Gcm2 in those tissues. These ectopic domains go on to
express other parathyroid markers but do not migrate and develop into ectopic parathyroids. Differences in
the expression of Gcm2 in the chick, mouse and zebraﬁsh, correlate with changing patterns of Shh signalling,
indicating a conserved regulatory mechanism that acts to deﬁne pouch derivatives.r).
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
The developing face and neck arise from the pharyngeal arches, a
series of bulges that form either side of the developing head. The
arches comprise a core mesoderm enclosed in neural crest tissue, and
are surrounded externally by ectoderm and internally by endoderm.
During development, the endoderm and ectoderm invaginate to-
wards each other delineating the arches and forming, in between, a
separating membrane consisting of an endodermal pouch on the
inside and ectodermal cleft on the outside. As well as physically
deﬁning the pharyngeal region, the clefts and pouches also form
important structures, such as the ear-drums, parathyroids, tonsils,
thymus and ultimobranchial bodies (reviewed by Grevellec and
Tucker, 2010). Each pouch/cleft gives rise to a speciﬁc organ, although
this can vary considerably between different species.
The parathyroids develop from the caudal pouches, with two sets
of parathyroids developing from the third and fourth pouches in
humans and birds, while only one set forms from the third pouch in
rodents. The parathyroids are endocrine glands unique to tetrapods
that secrete a peptidic hormone essential for the regulation of calcium
and phosphate homeostasis named parathyroid hormone (PTH)
(Potts, 2005). The parathyroids can be detected early on in their
development by the expression of Gcm2 that turns on at E9.5 in themouse and HH20 in the chick (Gordon et al., 2001; Okabe and
Graham, 2004). Gcm2 has been shown to be an excellentmarker of the
early parathyroid, coming on in the anterior third pouch before other
classic parathyroid markers, such as PTH and CasR (Gordon et al.,
2001; Liu et al., 2007). In keeping with the restricted origin of the
parathyroids, in the mouse, Gcm2 expression is only observed in the
developing third pouch, while in the chick, expression is observed in
the third and fourth pouches with transient expression also being
observed in the second pouch (Okabe and Graham, 2004).
Unlike the terrestrial vertebrates, ﬁsh do not develop parathyroids.
Still, they display Gcm2 expression in the arches. Indeed, in the
zebraﬁsh, Gcm2 is progressively activated in the epithelium of the
third to seventh pharyngeal arches from 32- to 72 hpf. It is transiently
expressed in a portion of the ﬁrst and second arches from 40- to
48 hpf. Later in development, Gcm2 remains evident in the gill
epithelium until at least E5 (Chang et al., 2009; Hanaoka et al., 2004;
Hogan et al., 2004; Okabe and Graham, 2004). The expression of Gcm2
in the pharyngeal arch epithelium and the gill buds, which are derived
from this region, has led to the hypothesis that the gills are
evolutionarily related to the tetrapod parathyroid gland (Okabe and
Graham, 2004). Indeed, the Gcm2-expressing internal gill buds also
express PTH and CasR and are therefore likely to contribute to the
regulation of extracellular calcium (Okabe and Graham, 2004).
Various signalling molecules and transcription factors have been
linked to the development of the pouch derivatives, with loss of ex-
pression leading to defects in initiation, size and migration (Grevellec
and Tucker, 2010). The signals important in initially deﬁningwhat organ
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studies in mouse have demonstrated the presence of the Hh pathway
genes Shh and Ptc1 in the developing pharyngeal apparatus (Echelard
et al., 1993; Goodrich et al., 1996; Hahn et al., 1996; Moore-Scott and
Manley, 2005; Platt et al., 1997;Washington Smoak et al., 2005). Ptc1 is
induced by Shh signalling and is an excellent read out of Shh signalling.
In themouse embryo from E9.5 to E12.5, both Shh and Ptc1 are spatially
and temporally differentially activated within the pharyngeal region,
with the anterior arches and pouches being subjected to higher Hh
signalling than the posterior arches and pouches (Moore-Scott and
Manley, 2005). This graded expression of Shh signalling has been sug-
gested to play a role in providing the patterning information for the
pouches, deﬁning them into anterior domains with high Shh activity,
and posterior/caudal domains with low or no Shh activity (Moore-Scott
andManley, 2005). Loss of Shh in the null mouse, leads to defects in the
formation of all the arches and pouches,with loss of expression ofGcm2,
indicating that Shh plays an important positive role in patterning the
anterior and caudal pouches. We wished to investigate the relationship
of Shh and parathyroid development, looking at the timing of Shh sig-
nalling during development of the caudal pouches in order to under-
stand its relationship to the parathyroid marker Gcm2, and its role in
restricting the development of the parathyroids to the caudal pouches.
Materials and methods
Collection of chicken embryos
Fertilised leghornhen's eggswere incubated forup to10 days at 38 °C
in ahumidiﬁed atmosphere. Embryo stagingwasdetermined referring to
the normal stages of chicken development series of Hamburger and
Hamilton (1992). At the required stage, embryoswere removed from the
eggs and the extra-embryonic membranes removed. Then, the embryos
were ﬁxed overnight at 4 °C in freshly prepared 4% paraformaldehyde
(PFA).
Collection of mouse embryos
Pregnant CD1micewere sacriﬁced by cervical dislocation. Noon on
the day of discovery of the vaginal plug was designated E(embryonic
day) 0.5. Embryos were harvested, decapitated and ﬁxed overnight at
4 °C in freshly prepared 4% paraformaldehyde (PFA).
Collection of zebraﬁsh embryos
24 hpf wild-type zebraﬁsh embryos were raised until the desired
stages at 28.5 °C in 35 mm Petri dishes ﬁlled up with E3 medium
(5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl 2, and 0.33 mMMgSO4). No
methylene blue was added to the medium as this antifungal solution
was reported to cause autoﬂuoresence when analysing the embryos
by whole mount ﬂuorescent ISH (Welten et al., 2006). Each Petri dish
contained about 25 embryos and the medium was replaced every
day. At 72 hpf, the embryos were placed onto cold-iced water for
immobilisation and ﬁxed in 4% PFA.
In-ovo cyclopamine injection
Cyclopamine (Sigma) was prepared in 45% 2-hydroxypropyl-B-
cyclodextrin (Sigma) and diluted in PBS at a concentration of 2.43 M.
At the desired stage, 15 μL to 30 μL of cyclopamine depending on the
age of the embryo was administered as described by Cordero et al.
(2004). Control embryos received a solution of 2-hydroxypropyl-B-
cyclodextrin in PBS injected in a similar manner. After manipulation,
the shell opening was sealed and the eggs were returned into the
incubator. The embryos were left to develop up to E10 before further
ﬁxing.Parafﬁn wax tissue sectioning
Following ﬁxation in 4% paraformaldehyde at 4 °C, wildtype and
experimental embryos were dehydrated through an ethanol series
and embedded in parafﬁn wax. Eight-micrometre sections were cut
and serially laid out over four superfrost plus slides. Sections from the
E10 embryos were stained using a trichrome stain (haemotoxylin,
alcian blue, and sirrus red).
In-situ hybridisation on whole-mount and parafﬁn wax sections of chick
and mouse embryos
In situ hybridisation on chick embryonic tissues were carried out
using the following DIG-labelled anti-sense riboprobes: Gcm2, line-
arised with Nco1 and transcribed with Sp6, Shh, linearised with Sal1
and transcribed with Sp6; Ptc1, linearised with Sal1 and transcribed
with T3; FgF8, linearised with BamH1 and transcribed with T7; Bmp4,
linearised with BamH1 and transcribed with T3; Pax1, linearised with
XbaI and transcribed with T3; Eya1, linearised with Not1 and
transcribed with T3; and CasR, linearised with Sal1 and transcribed
with T7. PTH expression was detected using a mixture of PTH-3′ and
PTH-5′ antisenses riboprobes. PTH-3′ was linearised with Sal1 and
transcribed with T7; while PTH-5′ was linearised with Nco1 and
transcribed with Sp6. For the mouse tissue Ptc1 was linearised with
BamH1 and transcribed with T3, while Gcm2was linearised with Nco1
and transcribed with Sp6. Whole mount in situ hybridisations were
performed as described previously (Mootoosamy and Dietrich, 2002).
For in-situ hybridisation on wax sections, the sections were
deparafﬁnised with Histoclear (Histo-Clear II, National Diagnostics)
and rehydrated through an ethanol series. Then, they were treated
with Proteinase K (20 μg/mL for 15 min), ﬁxed for 20 min with PFA,
and placed at 65 °C in a humidiﬁed chamber for overnight hybridisa-
tion with the DIG-labelled riboprobes diluted in 50% formamide,
5 mM EDTA, pH 8; 25 μg/mL heparin; 2% Tween20; 1.28X SSC; and
0.05 mg/mL yeast RNA. The following day, the slides were washed
once in 2X SSC, 50% formamide, 0.1% Tween 20, and twice in 1X SSC
for 30 min at 65 °C. They were then taken through three 30 min
washes at RT in MABT (0.15 M NaCl, and 0.1 M maleic Acid; 0.1%
tween), before blocking for 2 h in 10% goat serum (Sigma), and
overnight incubation at 4 °C with the anti-DIG Fab fragment alkaline
phosphatase conjugate antibody (Roche Diagnostics) (1:1000). Sub-
sequently, the unbound antibodies were cleared off by four MABT
washes, and a diluted staining solution of NBT/BCIP (Roche Diag-
nostics) was applied onto the tissues until a colour develops. The
reaction was stopped with PBT, and the sections were dehydrated
through an ascendant ethanol series. Previous to mounting, the
tissues were lightly counterstained in pink by eosin.
Double ﬂuorescent in-situ hybridisation on whole-mount zebraﬁsh
embryos
The steps of preparation of the embryos, hybridisation, post-
hybridisation washes, and post-antibody washes were performed as
described in Clay and Ramakrishnan (2005). The antibody detection
of the labelled probes was carried out using the TSA-Plus Fluorescent
System (Perkin Elmer Life Science) following the protocol detailed in
Denkers et al. (2004). Gcm2was linearised by Sal1 and transcribed by
T7; Ptc1 was linearised by BamH1 and transcribed by T3.
Results
Shh signalling is excluded from, or reduced in, the Gcm2 expression
Differential expression of Shh and Ptc1 within the pharyngeal
pouches of the different arches has previously been observed in the
mouse at E10.5 and E11.5 (Moore-Scott and Manley, 2005). To
Fig. 2. Expression analysis of Gcm2, Ptc1 and Shh in the chick pharyngeal pouch area at HH21–24. (A): At HH21, Gcm2 is detected in the third pouch (p3). (B): At HH24, it is also seen
in the fourth pouch (p4). On frontal sections, Gcm2 is visible in the anterior endodermal portion of the third and fourth pouches (p3 and p4 arrows). (C):At a more ventral level,
additional faint Gcm2 labels the lateral posterior second arch and anterior third arch epithelium (arrowheads). (D and E): Ptc1 is expressed in the anterior half of the ﬁrst cleft
ectoderm (arrow) as well as in the surrounding lateral mesenchyme of the posterior ﬁrst arch. (F): On a serial section Shh is co-expressed with Ptc1 in the cleft ectoderm (arrow).
(G): Gcm2 is present in the third pouch, whereas it is not detected in the ﬁrst and second pouches and cleft epithelium. (H and I): On serial sections, Ptc1 (H) and Shh (I) appear
prominent in the posterior ectodermal margin of the second arch (arrowheads). Ptc1 but not Shh is expressed in the ﬁrst and second pouches (p1 and p2). (J): In the anterior third
pouch, the presumptive parathyroid domain is marked by the presence of Gcm2 (arrow). (K): On a serial section, Ptc1 is present in the third and fourth archmesenchyme andmedial
endoderm, but is restricted from the Gcm2-expressing pouch endoderm (arrow), as well as from the posterior part of the third pouch. (L): On a serial section, Shh is expressed in the
medial arch endoderm, but is absent from the entire third pouch endoderm. The scale-bars correspond to 500 μm in (A), and 100 μm in the other panels. The boxes in (D and G–I)
show the region highlighted in (E and F) and (J–L) respectively. The diagrams on the left show the plane and orientation of the sections in (D–L). PA = pharyngeal arch and
c = pharyngeal cleft.
Fig. 1. Expression analysis of Gcm2 and Ptc1 in the mouse pharyngeal epithelium at E10.5. (A and B): No Gcm2 is detected in the mouse' ﬁrst cleft area (c1). (C): In contrast, the ﬁrst
cleft ectoderm strongly expresses Ptc1 (arrow). (D, E): Gcm2 labels the anterior part of the third pouch (p3) endoderm (arrow). (F): On serial section, this tissue shows reduced Ptc1
expression (arrow). (A and B) are frontal sections. PA = pharyngeal arch. Scale-bars represent 200 μm.
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Fig. 3. Expression of Gcm2 and Ptc1 at 3 dpf in the zebraﬁsh pharyngeal pouch region. Confocal analysis in the head region of a 3 dpf zebraﬁsh embryo subjected to double whole-
mount ISH for Gcm2 (red) and Ptc1 (green). (A, E and I): Merged images of Ptc1 and Gcm2 at distinct medio-lateral levels of the same embryos. (B, F and J): View at higher
magniﬁcation (×63) of the arch area squared in the panels (A), (E) and (I) respectively. The numbers indicate the name of the pharyngeal arches. (C, G and K): Ptc1 labels the entire
pouch endoderm. (D, H and L): Gcm2 labels the arch epithelium.
Fig. 4. Early expression of Shh and Ptc1 in the chick pharyngeal arches. Whole-mount
ISH for Shh and Ptc1 on wild-type embryos at HH16. (A): Shh is expressed in the foregut
endoderm as well as in the second pouch epithelium. (B): Ptc1 is present in the oral
ectoderm and mesenchyme as well as in the posterior aspect of each developing arch.
Arrows indicate the third pouch.
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expression of Ptc1 with Gcm2 at E10.5, when the endoderm pouches
are clear. As previously shown, Ptc1 was found at high levels in the
rostral pouches, where there is no Gcm2 expression, while in the
Gcm2 positive third pouch expression of Ptc1 was at much lower
levels, in the region where Gcm2 was expressed (Fig. 1). To test
whether this reduction of Shh signalling in the Gcm2 expressing
caudal pouches was also observed in other species with different
patterns of Gcm2 expression, we turned to the chick and zebraﬁsh
that have very different expression patterns of Gcm2 during pharyn-
geal arch development.
In the chick, Gcm2was ﬁrst detected in the third pharyngeal pouch
at HH21 (Fig. 2A). By HH23–24, expression increased in the third
pouch, and was initiated in the fourth pouch, in the dorsal anterior
portion of the endodermal outpocketings (Fig. 2B). In addition Gcm2
was faintly transcribed in a limited domain of the caudal second arch
and rostral third arch epithelium in a few embryos (Fig. 2C, arrow-
heads, 3/7 embryo). This second arch expression domain was
transient, with only 2 out of 24 embryos retaining Gcm2 expression
in the second pouch by HH26.
In the rostral arches, Shh was expressed in a restricted fashion
throughout the medial pharyngeal endoderm, as well as in the
external anterior part of the ﬁrst cleft (Fig. 2F), and in the posterior
margin of the second arch (arrowhead Fig. 2I). Meanwhile, Ptc1colocalised with Shh in the ﬁrst and second clefts, as well as in the
pharyngeal medial endoderm (Fig. 2D, E, and H). In addition, it was
present throughout the ﬁrst and second arch mesenchyme, as well as
in the ﬁrst and second pouches, with strong expression levels in the
areas surrounding the Shh transcripts (Fig. 2H and I). In the caudal
pharyngeal region, Ptc1 expression was prominent in the medial
aspect of the third and fourth arch mesenchyme (Fig. 2H and K).
Fig. 5. Effect of in-ovo cyclopamine administration at HH16–17 on gene expression in the pouch area at HH21–23. Embryos treated with 15–20 μL of control HbC vehicle (A–E, K–N)
or cyclopamine (F–J, O–R) at HH16–17 and analysed for gene expression in the pharyngeal region at HH21–23. (B and G), (L and N) and (P and R) show at higher magniﬁcation the
zones squared in (A and F), (K and O) and (M and Q) respectively. (A–E): In the controls, Ptc1 (A and B) is expressed throughout the pharyngeal arches; Gcm2 (C) is expressed in the
anterior part of the third pouch; and Bmp4 (D and E) is expressed in the dorsal posterior aspect of the third pouch. (F–J): Following cyclopamine treatment, Ptc1 (F and G) is
signiﬁcantly reduced in the arches; Gcm2 (H) is reduced or abolished in the third pouch (p3) whereas Bmp4 (I and J) appears upregulated in the fourth pouch (p4, arrow). (K–N): in
the controls, Tbx1 (K and L) is strongly expressed in the arch mesenchyme, and is also visible in the third and fourth pouches, while Eya1 (M and N) is present throughout the arch
mesenchyme and epithelium. (O–R): In the embryos exposed to cyclopamine Tbx1 (O and P) is reduced in the arch mesenchyme and epithelium, including in the third and fourth
pouches, while Eya1 (M and N) appears decreased in the second arch as well as in the medial aspect of the third and fourth arch mesenchyme and epithelia. Scale bars represent
500 μm in (A, F, K, M, O and Q).
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medial endoderm, they appeared excluded from the zone of the third
pouch expressing Gcm2 (Fig. 2G, J–L). Similar observations weremade
in the fourth pouch at HH24 (data not shown).
We also investigated the expression pattern of Ptc2, which in the
chick, unlike the mouse, is responsive to Hh signalling. A similarFig. 6. In-ovo cyclopamine administration at HH20 ectopically activates Gcm2 expression in
control HbC vehicle (D, J, P, and V) or cyclopamine (A, G, M, and S) at HH21 and analysed fo
squares in the left panels indicate the zones shown at higher magniﬁcation in the adjacent pa
(p1) and cleft (c1), including in the anterior part of the cleft (arrow). (C): On a serial secti
controls at HH24, Ptc1 is evident in the anterior ﬁrst pouch and cleft (arrow). (F): On an adja
Ptc1 appears strongly downregulated at HH24 in a domain of the posterior second arch ep
expression (arrows). (J and K): In the controls at HH24, Ptc1 is expressed at a high level thro
appears smaller than the one seen in the cyclopamine treated animals (compare H and K, ar
epitheliumwhere Ptc1 is absent (arrows). (M–R): In the third pouch of the controls (M–O) an
Gcm2 is robust (arrows, O and R). (S and T): At HH27–28, reduced Ptc1 is detected in the ﬁrst
in the anterior ﬁrst cleft ectoderm. (V–W): At HH27–28 the controls still display Ptc1 in the
(Y): On an adjacent section, no Gcm2 is detected in the anterior ﬁrst cleft. The diagrams on the
bars in (A–H) stand for 100 μm. PA = pharyngeal arches.exclusion of Ptc2 from the caudal pouch endodermwas shown by Ptc2
(data not shown).
Therefore, in the chick as in mouse, Hh pathway activity,
evidenced by Ptc1 and Ptc2 expression, appears higher in the anterior
than in the posterior arches. In addition, whereas it is present in the
rostral pouches, it appears weak or absent in the third and fourththe ﬁrst cleft and posterior second arch epithelium. Embryos treated with 30–50 μL of
r Ptc1 and Gcm2 in the pharyngeal region by ISH at HH24 (A–R) or HH27–28 (S–Y). The
nels. (A–B): In the cyclopamine-treated embryos at HH24, Ptc1 is weak in the ﬁrst pouch
on, Gcm2 is present in the anterior aspect of the cleft ectoderm (arrow). (D–E): In the
cent section, Gcm2 is absent from these tissues (arrow). (G, H): Following Hh inhibition,
ithelium (H, arrow). (I): On an adjacent section, this domain shows prominent Gcm2
ughout the caudal second arch margin, except in a limited area of the epithelium, which
rows). (L): On a serial section, Gcm2 is detected in the zone of the posterior second arch
d cyclopamine-exposed embryos (P–R), virtually no Ptc1 is detected (N and Q)whereas
cleft of the cyclopamine-treated embryos. (U): On a serial section, ectopic Gcm2 is seen
anterior ﬁrst cleft, even though expression levels seem reduced compared with HH24.
left-hand side of the ﬁgure indicate the plane and orientation of the sections. The scale-
199A. Grevellec et al. / Developmental Biology 353 (2011) 194–205endodermal outpocketings, particularly at the level of the presump-
tive parathyroid. Finally, interestingly, Hh pathway activity appeared
especially concentrated in conﬁned areas of the anterior ﬁrst and
second clefts.
Whereas, in mouse or avian embryos, early Gcm2 expression is
restricted to the anterior part of the caudal pouch endoderm, in ﬁsh it
is primarily conﬁned to the pharyngeal arch epithelium (Hogan et al.,2004; Okabe and Graham, 2004). In zebraﬁsh, Shh, Ptc1 and Ptc2
transcripts have been reported in the gill area from 32 hpf to 72 hpf
(Krauss et al., 1993; Lewis et al., 1999). We therefore wished to see
whether Gcm2 and Ptc1 expressions in the zebraﬁsh are also mutually
exclusive in the developing pouches and clefts.
Our expression analysis reveals that at 72 hpf, Ptc1 is present
throughout the pharyngeal pouch endoderm up to the lateral tips of
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epithelium, including the clefts (Fig. 3C, G, and K). Gcm2 is excluded
from the pharyngeal pouch endoderm, while it is prominent in the
arch ectoderm, as well as in the ectodermal groove (Fig. 3D, H, and L).
Overall, Ptc1 and Gcm2 expression appear strictly restricted from each
other, with Ptc1 expression marking the pharyngeal pouch, and Gcm2
expression labelling the pharyngeal arch epithelium and the cleft (Fig.
3B, F, and J).
Gcm2 expression is therefore localised to regions with low or no
Shh signalling in mouse, chick and zebraﬁsh.Fig. 7. Ectopic Gcm2 expression overlaps with Fgf8 and Pax1 but not Hoxa3 or Bmp4 in the ﬁ
arches (A) as well as the posterior aspect of the second arch epithelia (arrow, a’), whereas it i
higher magniﬁcation in (a) and (a’). (B–M): Embryos treated with 30 μL of control HbC veh
expression in the ﬁrst cleft at HH24–26. (C, F, I, and L) and (D, G, J, and M) are serial sections
ﬁrst cleft (red arrowheads). (B): The controls show absent Hoxa3 expression in the ﬁrst cleft
In the controls, Fgf8 is present in restricted domains of the anterior and posterior cleft (black
overlaps with ectopic Gcm2 (F, G, red arrowheads). (H): In the controls, Bmp4 is expressed i
such expression is unaffected. Ectopic Gcm2 is excluded from the Bmp4 domain (red arrowhe
(black arrow). (M): Pax1 is unchanged in the embryos exposed to cyclopamine; it partly ove
and 200 μm in the other panels. The approximate plane and orientation of the sections ar
p = pharyngeal pouch.Early loss of Shh signalling in the chick mimics the Shh null mutant with
loss of the parathyroid
Analysis of the Shh null mutant mouse has shown that patterning
of the third pharyngeal pouch is dependent on Shh signalling (Moore-
Scott and Manley, 2005). In the Shh knockout, the pattern of the
pharyngeal pouches is disrupted and in the third pouch the Gcm2
expression domain is lost while the neighbouring Bmp4 expressing
presumptive thymus domain expands. We therefore treated chick
embryos in ovo with cyclopamine at HH14–16, before the onset ofrst cleft. (A, a and a’): At HH24 in the WTs, Hoxa3 is expressed in the third and fourth
s excluded from the ﬁrst pouch and cleft. The squares in (A) indicates the areas shown at
icle (B, E, H, and K) or cyclopamine (C, F, I, and L) at HH20–22 and analysed for gene
. (C, F, I, and L): Cyclopamine treatment leads to ectopic Gcm2 activation in the anterior
. (D): Similarly, the cyclopamine-treated embryos display no Hoxa3 in the ﬁrst cleft. (E):
arrow, E). (G): In the cyclopamine-exposed embryos, Fgf8 appears unchanged; it partly
n the posterior part of the cleft (black arrow). (J): In the cyclopamine-treated embryos,
ads I, J). (K): In the controls, Pax1 is evident in the anterior and distal portion of the cleft
rlaps with ectopic Gcm2 (red arrowhead, L, M). The scale-bars represent 1000 μm in (A)
e indicated on the diagram on the left. PA = pharyngeal arch; c = pharyngeal cleft;
201A. Grevellec et al. / Developmental Biology 353 (2011) 194–205Gcm2 expression. At this time-point Shh is expressed in the foregut
endoderm and second pouch epithelium, with active Shh signalling, as
indicated by Ptc1 expression, located at the base of each developing
arch (Fig. 4). After treatment with cyclopamine the embryos were left
to develop until HH21–23. Conﬁrming that the cyclopamine was
functional in the embryos at this stage, Ptc1 expression was clearly
reduced in specimens subjected to the teratogen (Fig. 5A and F). This
early treatment resulted in a failure of Gcm2 expression to initiate and
enhanced Bmp4 expression in the caudal pouches, while all arches
demonstrated a reduction in Tbx1 and Eya1, two key transcription
factors with roles in pharyngeal arch patterning, when analysed at
HH21–23 (Fig. 5C–E, H–R). These experiments thus conﬁrm that Shh
plays an important role in patterning the pharyngeal arches at early
stages of development. No change in Hoxa3 gene expression was
observed, indicating no change in the overall layout of the embryo
(data not shown).Later loss of Shh signalling leads to ectopic expression of Gcm2 in the
anterior pouches
Despite this early positive role of Shh on pharyngeal arch patterning,
and Gcm2 expression, the exclusion of Shh signalling in the chick caudal
pouch endoderm indicates that at later stages of pharyngeal pouch
development Shh signallingmay inhibit Gcm2 expression.We therefore
inhibited Shh signalling, using cyclopamine in ovo, but at later stages
once the arch pattern is set up and Gcm2 is induced in the third pouch.
Speciﬁcally, we wished to test whether inhibition of Shh signalling
would lead to an upregulation of parathyroid markers in the anterior
pouches.Fig. 8. CasR is upregulated in the cyclopamine-induced Gcm2-expressing domains. Embryos
HH20–22 and analysed for gene expression in the pouch and cleft regions at HH24–26. (A and
the posterior aspect of the ectodermal groove. (C): In the embryos treated with cyclopamin
section, CasR is visible in the posterior cleft (black arrow), but also in the anterior aspect of
Gcm2 is detected in the posterior second arch epithelial margin (red arrowhead). (F): On
Cyclopamine treatment leads to Gcm2 upregulation in the posterior second arch epithelium
Gcm2 domain (red arrowhead). (I and J): Gcm2 (I) and CasR (J) are co-expressed in the third p
the third pouch of the cyclopamine-treated embryos (red arrowheads). Scale-bars represen
diagram on the left hand side of the ﬁgure. PA = pharyngeal arch; c = pharyngeal cleft; pRelative to the controls, Hh inhibition at later stages (HH21) caused
no apparent change in Gcm2 transcription level in the third pouch
(Fig. 6O and R, 8/8). It is possible that slight changes in expression
occurred but could not be assessed by in situ. In the posterior second
arch epithelial margin, where a transient Gcm2 positive domain is
observed in controls, application of cyclopamine increased the extent
of Gcm2 expression, with the area of expression being signiﬁcantly
larger and persisting longer in the cyclopamine-treated embryos com-
pared to the controls (Fig. 6I and L) (N=3/19 in controls and N=21/
29 cyclopamine treated). Moreover, in the anterior ﬁrst ectodermal
cleft, cyclopamine treatment induced a completely new Gcm2 ex-
pression domain in 18/21 embryos (Fig. 6C), whereas expression of
this gene in the ﬁrst pouch/cleft was never evidenced in the controls
(Fig. 6F, 0/15).
In the anterior ﬁrst and second clefts and pouches of the controls,
strong Ptc1 was detected throughout the epithelium, except in the
limited caudal second arch epithelial zone that occasionally expressed
Gcm2 (Fig. 6E and K, N=4/4). By contrast, in the embryos exposed to
cyclopamine, highly reduced Ptc1 was observed in the ectopic Gcm2
positive area of the ﬁrst cleft and posterior second arch (Fig. 6B and H,
N=3/3). There is thus a clear correlation between loss of Ptc1 and
upregulation of Gcm2, in the lateral posterior ﬁrst and second arch
epithelia. The presence of active Hh signalling may therefore prevent
the transcription of Gcm2.
Interestingly, subjecting the embryos to cyclopamine at HH24 simi-
larly resulted in ectopic Gcm2 activation in the rostral ﬁrst ectodermal
groove at HH27–28 (Fig. 6U and Y, 7/10). Again, this activation of Gcm2
was correlated with a local diminution in Ptc1 transcripts (Fig. 6T
andW).Maintained Shh signalling in the anterior pouches fromHH21 to
27 may therefore be necessary to repress the expression of Gcm2.treated with 30 μL of control HbC vehicle (A, E, and I) or cyclopamine (C, G, and K) at
B): In the controls, no Gcm2 (A) is detected in the ﬁrst cleft, while CasR (B) is evident in
e, ectopic Gcm2 is seen in the anterior ﬁrst cleft (red arrowhead). (D): On an adjacent
the latter, where it is co-expressed with Gcm2 (red arrowhead). (E): In some controls,
a serial section, CasR co-localises with this Gcm2 expression (red arrowhead). (G):
. (H): On an adjacent section, CasR expression is evident in the cyclopamine-induced
ouch of the controls. (K and L): Similarly, Gcm2 (K) and CasR (L) appear co-expressed in
t 200 μm. The approximate plane and orientation of the sections are indicated on the
= pharyngeal pouch.
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In the mouse Gcm2 is restricted to the third and fourth pouches,
while in the chick a transient expression is also observed in the second
arch.Gcm2 expression is thought to be expressed downstreamofHoxa3,
and in keeping with this Gcm2 expression is lost in Hoxa3mutants (Su
et al., 2001). In the mouse, the level of Hoxa3 extends up to the third
pharyngeal arch so that the third and fourth pouches are both Hoxa3
positive, while the ﬁrst and second pouches are Hoxa3 negative (Hunt
and Krumlauf, 1992; Manley and Capecchi, 1995, 1998; Manley et al.,
2004). The other Hox3 genes are expressed in the caudal arches but not
in the pouches at this stage (Manley and Capecchi, 1998). A similar
boundary of Hoxa3 is observed in the chick at HH18 (Hunt et al., 1998).
However, during later development in the chick (HH24–26), the level of
Hoxa3 extends more anteriorly up to and including the second pharyn-
geal pouch (Fig. 7A). The transient second arch expression domain of
Gcm2 overlaps with this later extended expression domain of Hoxa3
(Fig. 7a and a’). The timing and position of the transient second pouch
expression domain is therefore tightly linked with the expression of
Hoxa3. Given this ﬁnding, wewished to assess whether the ectopic ﬁrst
arch expression domain of Gcm2 induced after cyclopamine treatment
was also linked with a change in the expression of Hoxa3. Embryos
treated with cyclopamine at HH20–24 were selected for ectopic Gcm2
activation in the ﬁrst cleft. In the ﬁrst cleft and caudal second arch
epithelium of the cyclopamine-subjected embryos (5/5), Hoxa3 ex-
pression was normal compared with the controls, implying that the
ectopic Gcm2 expression visible in these areas does not reﬂect a change
in pharyngeal arch patterning (Fig. 7B, C, and D).
The ectopic Gcm2 domain in the ﬁrst pouch and cleft is restricted to
the anterior half of the epithelium, and was not observed more pos-
teriorly despite the lack of Shh signalling in this region (Fig. 6U and Y).
This indicated that another factor might be restricting the expression of
the ectopic Gcm2. In normal third pouch development the developing
parathyroids are positively regulated by Fgf8 and Pax1 (Abu-Issa et al.,
2002; Franket al., 2002; Liu et al., 2007; Su et al., 2001;Vitelli et al., 2002;
Wallin et al., 1996), and negatively regulated by Bmp4, expressed in the
thymus domain (Patel et al., 2006; Gordon et al., 2010). Interestingly,
Bmp4 is also expressed in the posterior domain of the ﬁrst pharyngeal
pouch and is excluded from the more anterior region (Fig. 7H). In the
cyclopamine treated embryos, the ectopicGcm2 expressionwas located
in the anterior domain and did not extend into the Bmp4 region (Fig. 7I
and J). Fgf8 and Pax1 transcripts were expressed in the ﬁrst pouch/cleft
epithelium in control embryos in both the anterior and posteriorFig. 9. Hh signalling inhibition by cyclopamine highly impairs the development of the extern
or cyclopamine (D–F) at HH20–22 and dissected for analysis at E9. Sections in the external ea
Red. (A and B): In the controls, the ﬁrst cleft developed into the external auditory meatus (
ectomesenchyme condensed into extracolumella cartilage (Exc); (C): The control foremimbs
invaginate and form the external ear canal, and no recognisable tubotympanic structure and
of the cyclopamine-exposed embryos. PA = pharyngeal arch, U = ulna, R = radius. Scale-domain, but the expression overlapped only in a part of the anterior
region (Fig. 7E andK). In cyclopamine treated embryos the ectopicGcm2
expression was found to overlap with these two factors, indicating that
these two genes may be required for Gcm2 expression (Fig. 7F, G, L, and
M). In each case the expression of Bmp4, Pax1 and Fgf8 in the pharyngeal
epithelium was not affected by the cyclopamine treatment (N=5/5).
Loss of Shh signalling leads to ectopic expression of CasR but not PTH
In order to determine whether other parathyroid-speciﬁc genes
may be ectopically activated in the anterior ﬁrst cleft and/or posterior
second arch epithelium following cyclopamine treatment, Hh-deplet-
ed embryos were analysed for CasR and PTH (parathyroid hormone)
expression (Fig. 8 and Fig. S1). In the controls, CasRwas co-expressed
withGcm2 in the third pouch (Fig. 8I and J, 5/5). ExpressionofCasRwas
also observed in the secondpouch in those embryos that showedGcm2
expression in this area (Fig. 8E and F 1/8). In addition, CasR was
apparent in the caudal portion of the ﬁrst cleft (Fig. 8B, 5/5), a region
not associated with Gcm2 or parathyroid development. Interestingly,
after inhibition of Shh signalling, CasR was upregulated with ectopic
Gcm2 in the rostral ﬁrst cleft (Fig. 8C and D, N=3/5), and in the
expanded Gcm2 expression domain in the posterior second arch
epithelium (Fig. 8G and H N=3/5). The co-expression of Gcm2 and
CasR, two parathyroidmarkers, indicates that the ﬁrst and second cleft
regions had been transformed to a parathyroid fate. As CasR expression
does not correlate speciﬁcally with Gcm2, we also investigated the
expression of PTH. PTH is expressed later than Gcm2 and CasR in the
chick, once the parathyroids are already morphologically deﬁned and
have started to migrate. At HH26 no expression of PTH was observed
(data not shown). From HH28 onwards PTH was expressed clearly in
the third and fourth pouches, with no expression in the more rostral
pouches (Fig. S1B and H). After treatment with cyclopamine no
evidence of PTH in the ﬁrst or second pouch/cleft epithelium was
observed, despite strong ectopic expression of Gcm2 (Fig. S1E and F
N=0/9). This would imply that loss of Shh signalling is not enough to
create ectopic, functional parathyroids.
Ectopic Gcm2/CasR domains do not form ectopic parathyroids
In order to investigate whether ectopic parathyroids developed in
our cyclopamine treated embryos, and to assess the consequence of
Gcm2/CasR ectopic expression on the normal development of the ﬁrst
cleft, we treated embryos with cyclopamine at late stages as beforeal and middle ear. Embryos were administered with 30 μL of control HbC vehicle (A–C)
r (A and D) and forelimb (C and F) regionwere stained with Alcian Blue/Chlorantine Fast
EAM), while the ﬁrst pouch formed the tubotympanic sulcus (Ts), and the second arch
show three digits. (D and E): In the cyclopamine-treated embryos, the ﬁrst cleft failed to
middle ear cartilage are recognisable; (F): Only one digit is recognisable in the forelimbs
bars represent 1000 μm in (A and D) and 100 μm in (C and F).
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hadwell-developed external ear canals, derived from the invagination
of the ﬁrst cleft (Fig. 9B). In the cyclopamine treated embryos,
however, the ear canal was often missing or severely reduced in size
(Fig. 9E, 6/9). These embryos also showed severe limb defects, as
would be expected from loss of Shh signalling (Fig. 9C and F). On
section, the ﬁrst arch cleft and pouch could be observed at a distance
from each other, the cleft forming a pocket of tissue, but no ectopic
parathyroids were identiﬁed in any of the embryos (9/9).
Discussion
We show here a striking relationship between the expression of
Gcm2 and low or no Shh signalling in the pharyngeal arches of mouse,
chick and zebraﬁsh. In the chick and zebraﬁsh we observed no
evidence of any Shh signalling in the Gcm2 positive domain, while in
the mouse very weak Ptc1 expression was evident, agreeing with
previous observations (Moore-Scott and Manley, 2005). It is possibleFig. 10. Effect of Hh signalling inhibition on gene expression in the pharyngeal epithelium.
illustrating the effect of Hh inhibition at HH16–17 on gene expression. Following cyclopamin
Ptc1 (A) is decreased throughout the pharyngeal epithelium, including in the anterior part of
(arrow); Bmp4 (C) is upregulated in the caudal pharyngeal pouches (arrows); Tbx1 (D) is do
third pouch. (E–H): Schematic frontal views of the pharyngeal region of HH24 chick em
expression in the pharyngeal epithelium is shown. The pharynx is coloured in light pink. The
decreases Ptc1 throughout the pharyngeal epithelium, and more particularly in the anterio
arrowhead). (F): Hh inhibition ectopically activates Gcm2 in the anterior ﬁrst cleft (pink arro
coincide with those of reduced Ptc1 (arrowheads in E, F). (G): Downregulation of Hh leads t
arch (pink and black arrowheads respectively). Such expression co-localises with ectopic Gc
epithelium of the third and fourth arches, including in the pouches, as well as in the posterior
arches, p = pharyngeal pouches, c = pharyngeal cleft, OV = otic vesicle.that very low levels of Shh signalling were also present in the chick
and zebraﬁsh Gcm2 positive domain, but were undetectable by in situ
hybridisation.
Interestingly, in chick embryos, transient expression of Gcm2 is
observed in the second pouch, while such expression has not been
reported in the mouse. This appears to correlate with a change in
Hoxa3 expression during pharyngeal arch formation, as at HH24
Hoxa3 expression expands anteriorly to encompass the second pouch
at the same time as the transient second pouch expression of Gcm2 is
observed. In zebraﬁsh, the expression of Gcm2 is also closely linked to
expression of Hoxa3 and Hoxb3 in the pharyngeal arch epithelium
from the onset of Gcm2 activation (Hogan et al., 2004). Reminiscent of
the Hoxa3−/− mice, the Hoxa3;Hoxb3 double morphants exhibit a
loss of Gcm2 in the gill epithelium (Hogan et al., 2004).
The inhibition of Hh signalling at different developmental stages
using in ovo cyclopamine injections in the chick revealed that the Hh
pathway plays distinct roles over time during parathyroid develop-
ment (illustrated in Fig. 10).(A–D): Schematic parasagittal views of the pharyngeal region of HH20 chick embryos,
e exposure at HH16–17 the pharyngeal arches are reduced in size compared to controls.
the third pouch; Gcm2 (B) is reduced or absent in the anterior aspect of the third pouch
wnregulated in the pharyngeal mesoderm and endoderm, including at the level of the
bryos, illustrating the effects of Hh inhibition at HH20 on gene expression. Only the
grade in colour illustrates the intensity of gene expression. (E): Cyclopamine exposure
r part of the ﬁrst cleft (pink arrowhead) and posterior second arch epithelium (black
whead) and posterior second arch (black arrowhead). The zones of Gcm2misexpression
o ectopic CasR activation in the epithelium of the rostral ﬁrst cleft and posterior second
m2 (compare F and G). (H): At HH24 in the controls, Hoxa3 is present in the pharyngeal
second arch epithelium. Cyclopamine at HH20 has no effect onHoxa3. PA= pharyngeal
204 A. Grevellec et al. / Developmental Biology 353 (2011) 194–205From around HH17 to HH20, Hh signalling is involved in setting up
the initial pattern of the pharyngeal arches. Disturbances in Shh
signalling at this stage lead to defects in patterning of the arches, the
third arch is perturbed, and there is no induction of Gcm2. However,
antagonising the Hh pathway after this stage, once arch pattern is
established, has no effect on the endogenous Gcm2 expression.
Strikingly, however, loss of Shh signalling at later stages led to ectopic
Gcm2 in the anterior ﬁrst cleft as well as in the anterior second pouch
or cleft. Ptc1 ISH on serial sections conﬁrmed that the aberrant
expression of Gcm2 observed in the drug-treated embryos were
associated with a local decrease in Ptc1 expression. Moreover, in the
occasional control embryos that displayed Gcm2 in the posterior
second arch epithelial margin, Ptc1 expression was found restricted
from the limited area of the epithelium transcribing Gcm2. All to-
gether, these data support the idea that the presence of active Hh
signalling from HH21 onwards in the anterior ﬁrst ectodermal cleft
and posterior second arch epithelium represses Gcm2, restricting the
development of parathyroids to the caudal pouches.
This may represent a common mechanism for restricting the
development of endodermally derived primordia. In the context of
thyroid and pancreas development, as in that of parathyroid genesis,
Shh is restricted from the endoderm-derived organ primordia,
whereas it is present throughout the surrounding endoderm
(Ahlgren et al., 1997; Apelqvist et al., 1997; Fagman et al., 2004;
Hebrok et al., 1998). Interestingly, in the Shh−/− mutants, ectopic
thyroid-speciﬁc protein expression was detected in the trachea
epithelium, which normally expresses Shh (Fagman et al., 2004).
Similarly, ectopic pancreatic speciﬁc markers were evidenced in the
stomach and duodenum primordium of chicken embryos injected
with cyclopamine (Kim and Melton, 1998). Thus, in developing
tetrapods, Hh signallingmay be required in the endoderm adjacent to
developing primordia in order to suppress the emergence of ectopic
organ derivatives. In the case of the parathyroids, ectopic Gcm2 was
not found in the endoderm adjacent to the anterior third pouch but in
some epithelia that, at least for the ﬁrst cleft, are ectodermal. Our
expression analysis showed that the anterior ﬁrst cleft and posterior
second arch epithelium, as the anterior third and fourth pouches,
display Fgf8 and Pax1 expressionswhereas they do not express Bmp4.
Thus these epithelia share common characteristics with the anterior
third or fourth pouches that allow Gcm2 activation in the absence of
Hh signalling.
No changes in Hoxa3 expression were noted in the Hh-depleted
animals, implying that the presence of ectopic Gcm2 expression in the
anterior arch epithelium of the latter does not reﬂect a change in the
pharyngeal arch identity. Upregulation of Gcm2 after cyclopamine-
treatment, was associatedwith upregulation of CasR. Mouse CasR does
not require Gcm2 for its activation in the pharyngeal pouches (Liu
et al., 2007). The CasR gene, however, includes a Gcm2 response
element in each of its two promoters, and in vitro transfection assays
have shown that Gcm2 is able to upregulate CasR in parathyroid cells
(Canaff et al., 2009). In the context of Hh inhibition, ectopic Gcm2may
therefore directly induce CasR misexpression in the pharyngeal
epithelium. Although we saw ectopic CasR associated with the ectopic
Gcm2, no ectopic expression of PTH was observed after cyclopamine
treatment. PTH expression comes on relatively late during chick
parathyroid development and the lack of ectopic expression indicates
that although ectopic parathyroids might have been initiated in the
rostral arches they were unable to undergo differentiation to form
parathyroid tissue. This agrees with the fact that no ectopic para-
thyroids were observed at later stages. It is perhaps not surprising
that the ectopic ﬁrst arch Gcm2/CasR positive tissue was unable to
form a normal parathyroid that can migrate as many of the factors
necessary for parathyroid migration or late differentiation, such as
Hoxd3 and Hoxb3 are expressed in the posterior pharyngeal pouches
but are missing in the anterior arch epithelium (Manley and Capecchi,
1998).The above data converge towards a model in which at HH21–24,
the absence of Hh signalling, together with the presence of Fgf8 and
Pax1 and the absence of Bmp4, are required in the pharyngeal epi-
thelium to allowexpressionofGcm2. Inmouse and zebraﬁsh,Hoxa3/b3
function is required for Gcm2 activation or maintenance in the pha-
ryngeal region. Still, in the cyclopamine-treated embryos, the absence
of Hoxa3 from the ﬁrst cleft Gcm2 ectopic domain provides evidence
that at least under Hh reduction, and in the presence of Fgf8 and Pax1,
Gcm2 in the pharyngeal epithelium does not rely on Hoxa3. One
possibility for reconciling all these observations is that Hoxa3 inhibits
the Hh pathway in the pharyngeal epithelium. In the third and fourth
caudal pouch, the negative regulation of Hh signalling byHoxa3would
stop the inhibition of Gcm2, whereas in the anterior arch epithelium,
the lack of Hoxa3would permit Hh driven suppression of this gene. It
would be interesting to test this hypothesis by investigating the effects
of mis-expressing Hoxa3 in the chick ﬁrst cleft on Gcm2 and Ptc1, and
by analysing Ptc1 in the Hoxa3−/−mice.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.02.012.
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